Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prima BioMed Ltd (NASDAQ:PBMD)

0.885
Delayed Data
As of Sep 23
 -0.0039 / -0.44%
Today’s Change
0.72
Today|||52-Week Range
1.54
-22.37%
Year-to-Date
Institutional investors purchased a net $135.0 thousand shares of PBMD during the quarter ended June 2016 and now own 0.34% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional0.33%
Mutual fund holders0.01%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2016UBS SECURITIES LLC  Bought 107.2 Thousand shares of Prima BioMed Ltd
6/30/2016NOMURA SECURITIES CO., LTD. (PRI...  Bought 37.2 Thousand shares of Prima BioMed Ltd
6/30/2016G1 EXECUTION SERVICES LLC  Bought 11.8 Thousand shares of Prima BioMed Ltd

Top 10 Owners of Prima BioMed Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
UBS Securities LLC0.16%112,46397,280+107,171+2,025.15%
Nomura Securities Co., Ltd. (Priv...0.05%37,22932,203+37,229--
Wedbush Securities, Inc.0.03%20,00017,30000.00%
BMO Capital Markets (Canada)0.03%20,00017,30000.00%
Citadel Advisors LLC0.02%16,30814,106-51,037-75.78%
G1 Execution Services LLC0.02%11,77010,181+11,770--
Deutsche Asset Management Investm...0.01%8,3227,199+8,260+13,322.58%
Marketocracy Capital Management L...0.01%3,8003,28700.00%
First New York Securities LLC0.00%00-140,000-100.00%
Morgan Stanley & Co. LLC0.00%00-33-100.00%

Top 10 Mutual Funds Holding Prima BioMed Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.01%3,8003,28700.00%